Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors |
|
https://doi.org/10.18632/oncotarget.27861
Erika J. Crosby,
H. Kim Lyerly,
and Zachary C. Hartman
|
| 1-3 |
Carving a niche for immunotherapy in ovarian cancer
Carving a niche for immunotherapy in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27864
Nitasha Gupta,
Erika Lampert,
and Jung-Min Lee
|
| 4-7 |
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy |
|
https://doi.org/10.18632/oncotarget.27865
Adam M. Sonabend,
Roger Stupp,
Catalina Lee-Chang,
and Hideho Okada
|
| 8-9 |
Combination therapies for MPNSTs targeting RABL6A-RB1 signaling
Combination therapies for MPNSTs targeting RABL6A-RB1 signaling |
|
https://doi.org/10.18632/oncotarget.27862
Jordan L. Kohlmeyer,
David J. Gordon,
Munir R. Tanas,
Rebecca D. Dodd,
Varun Monga,
Benjamin W. Darbro,
and Dawn E. Quelle
|
| 10-14 |
Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer
Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer |
|
https://doi.org/10.18632/oncotarget.27855
Krastan B. Blagoev,
Roumen Iordanov,
Mengxi Zhou,
Tito Fojo,
and Susan E. Bates
|
| 15-21 |
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment |
|
https://doi.org/10.18632/oncotarget.27859
Juyeon Ko,
April N. Meyer,
Martin Haas,
and Daniel J. Donoghue
|
| 22-36 |
Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model
Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model |
|
https://doi.org/10.18632/oncotarget.27857
Gerrit Spanier,
Daniela Weidt,
Dirk Hellwig,
Johannes K.H. Meier,
Torsten E. Reichert,
and Jirka Grosse
|
| 37-48 |
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation |
|
https://doi.org/10.18632/oncotarget.27858
Karim Abid,
Maja Beck Popovic,
Katia Balmas Bourloud,
Jacqueline Schoumans,
Joana Grand-Guillaume,
Eric Grouzmann,
and Annick Mühlethaler-Mottet
|
| 49-60 |
Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals |
|
https://doi.org/10.18632/oncotarget.27638
Pengjun Zhou,
Rong Zhang,
Ying Wang,
Dandan Xu,
Li Zhang,
Jinhong Qin,
Guifeng Su,
Yue Feng,
Hongce Chen,
Siyuan You,
Wen Rui,
Huizhong Liu,
Suhong Chen,
Hongyuan Chen,
and Yifei Wang
|
| 61-62 |
